- €336.88m
- €380.47m
- €201.81m
- 43
- 25
- 31
- 22
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 162 | 170 | 215 | 271 | 202 |
Cost of Revenue | |||||
Gross Profit | 82 | 88.7 | 113 | 132 | 85.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 145 | 150 | 186 | 242 | 224 |
Operating Profit | 17 | 20.1 | 28.6 | 28.9 | -21.9 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 16.9 | 20.4 | 28.2 | 28.3 | -20.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12.9 | 15.1 | 21 | 21.4 | -13.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 12.9 | 15.1 | 21 | 21.4 | -13.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 12.9 | 15.1 | 21 | 21.4 | -13.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.432 | 0.497 | 0.702 | 0.715 | -0.078 |
Dividends per Share |